Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

Bioscience

Enochian BioSciences (ENOB.Q) announced today that the Company has acquired an exclusive license for an innovative technology to potentially treat and prevent all variants of coronavirus, including the cause…
Lexaria Bioscience (LLX.C) announced today that treatment and dosing in its human clinical study, HYPER-H21-1, have been completed ahead of schedule.   “Completing this work in the midst of…
Xphyto Therapeutics (XPHY.C) subsidiary Xphyto Therapeutics entered into an agreement with Applied Pharmaceutical Innovation for the synthesis of pharma-grade psychedelic compounds and development of standard operating procedures to attract…
Sol Global Investments’ (SOL.C) 40.7% owned subsidiary Heavenly Rx, inked a memorandum of understanding (MOU) today to go public using Therapix Biosciences (TRPX.Q) for their reverse takeover. Sol originally…
On May 30, 2019 Crop Infrastructure (CROP.C) announced that Elite Ventures (in which CROP holds a 49% interest) has partnered with its licensee The Hempire Company to enter into…